TFA
TEVA icon

Transamerica Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Transamerica Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.27K Buy
126
+90
+250% +$3K ﹤0.01% 1160
2026
Q1 		$1.08K Buy
+36
New +$1.16K ﹤0.01% 1320
2014
Q4 		– Sell
-200
Closed -$11K – 761
2014
Q3 		$11K Hold
200
– – ﹤0.01% 467
2014
Q2 		$11K Buy
+200
New +$10.2K ﹤0.01% 493

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Transamerica Financial Advisors's TEVA Position: Q2 2026 in Review

Transamerica Financial Advisors increased its Teva Pharmaceuticals (TEVA) stake by 250% in Q2 2026, buying an estimated $3K and bringing the position to 126 shares worth $4.27K. The position accounts for ﹤0.01% of the portfolio, ranked #1160.

Transamerica Financial Advisors first reported a position in TEVA in Q2 2014 and has held it in 4 quarters since. The position peaked at $11K in Q3 2014. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Transamerica Financial Advisors held 126 shares of Teva Pharmaceuticals worth $4.27K as of Q2 2026.
  • Transamerica Financial Advisors bought 90 Teva Pharmaceuticals shares in Q2 2026, an estimated $3K.
  • Teva Pharmaceuticals made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1160 holding.
  • Transamerica Financial Advisors first reported a position in Teva Pharmaceuticals in Q2 2014 and has held it in 4 quarters since.
  • Transamerica Financial Advisors's Teva Pharmaceuticals position peaked at $11K in Q3 2014.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.